IL148345A0 - Methods of and compositions for inhibiting the proliferation of mammalian cells - Google Patents

Methods of and compositions for inhibiting the proliferation of mammalian cells

Info

Publication number
IL148345A0
IL148345A0 IL14834500A IL14834500A IL148345A0 IL 148345 A0 IL148345 A0 IL 148345A0 IL 14834500 A IL14834500 A IL 14834500A IL 14834500 A IL14834500 A IL 14834500A IL 148345 A0 IL148345 A0 IL 148345A0
Authority
IL
Israel
Prior art keywords
inhibiting
proliferation
compositions
methods
mammalian cells
Prior art date
Application number
IL14834500A
Other languages
English (en)
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Publication of IL148345A0 publication Critical patent/IL148345A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/27—Endoribonucleases producing 3'-phosphomonoesters (3.1.27)
    • C12Y301/27001—Ribonuclease T2 (3.1.27.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
IL14834500A 1999-08-30 2000-08-29 Methods of and compositions for inhibiting the proliferation of mammalian cells IL148345A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38541199A 1999-08-30 1999-08-30
PCT/IL2000/000514 WO2001015531A1 (en) 1999-08-30 2000-08-29 Methods of and compositions for inhibiting the proliferation of mammalian cells

Publications (1)

Publication Number Publication Date
IL148345A0 true IL148345A0 (en) 2002-09-12

Family

ID=23521271

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14834500A IL148345A0 (en) 1999-08-30 2000-08-29 Methods of and compositions for inhibiting the proliferation of mammalian cells

Country Status (15)

Country Link
EP (3) EP1207755B1 (de)
JP (2) JP4808346B2 (de)
AT (1) ATE421856T1 (de)
AU (1) AU769011B2 (de)
CA (1) CA2382303C (de)
CU (1) CU23065A3 (de)
DE (1) DE60041495D1 (de)
EA (1) EA004929B1 (de)
ES (3) ES2319096T3 (de)
HK (1) HK1045081B (de)
IL (1) IL148345A0 (de)
MX (1) MXPA02002162A (de)
NZ (1) NZ517579A (de)
WO (1) WO2001015531A1 (de)
ZA (1) ZA200201647B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7811981B2 (en) 1999-08-30 2010-10-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods of and compositions for inhibiting the proliferation of mammalian cells
MXPA02002162A (es) * 1999-08-30 2002-11-04 Yissum Res Dev Co Metodos de y composiciones para inhibir la proliferacion de celulas de mamifero.
CA2582041C (en) * 2004-09-29 2015-08-04 Levava Roiz Recombinant human t2 rnase and uses thereof
CZ302164B6 (cs) * 2008-06-20 2010-11-24 Biologické centrum AV CR, v. v. i. Rekombinantní rostlinná nukleáza jako protinádorové terapeutikum s nízkými nežádoucími úcinky
WO2015114633A1 (en) 2014-01-30 2015-08-06 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. Actin binding peptides and compositions comprising same for inhibiting angiogenes is and treating medical conditions associated with same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786457A (en) * 1989-02-23 1998-07-28 Colorado State University Research Foundation Hormone-nuclease compounds and method for regulating hormone related diseases
MXPA02002162A (es) * 1999-08-30 2002-11-04 Yissum Res Dev Co Metodos de y composiciones para inhibir la proliferacion de celulas de mamifero.
CA2582041C (en) * 2004-09-29 2015-08-04 Levava Roiz Recombinant human t2 rnase and uses thereof

Also Published As

Publication number Publication date
JP5467076B2 (ja) 2014-04-09
HK1045081B (en) 2009-08-07
ZA200201647B (en) 2003-05-28
EP2294918B8 (de) 2012-11-14
EA200200312A1 (ru) 2002-10-31
MXPA02002162A (es) 2002-11-04
AU769011B2 (en) 2004-01-15
EP2294918B1 (de) 2012-10-10
AU6722800A (en) 2001-03-26
WO2001015531A1 (en) 2001-03-08
EP1207755B1 (de) 2009-01-28
EP1207755A1 (de) 2002-05-29
ES2397052T3 (es) 2013-03-04
EP2165605A1 (de) 2010-03-24
JP2011251971A (ja) 2011-12-15
EP2294918A1 (de) 2011-03-16
DE60041495D1 (de) 2009-03-19
CU23065A3 (es) 2005-07-19
JP4808346B2 (ja) 2011-11-02
EP2165605B1 (de) 2012-10-10
EP1207755A4 (de) 2004-11-10
CA2382303C (en) 2013-02-12
NZ517579A (en) 2004-02-27
HK1045081A1 (en) 2002-11-15
EA004929B1 (ru) 2004-10-28
ES2396998T3 (es) 2013-03-01
CA2382303A1 (en) 2001-03-08
ATE421856T1 (de) 2009-02-15
HK1157137A1 (en) 2012-06-29
ES2319096T3 (es) 2009-05-04
JP2003508411A (ja) 2003-03-04

Similar Documents

Publication Publication Date Title
IL145475A0 (en) Compounds that inhibit impdh enzyme and pharmaceutical compositions containing the same
ZA981132B (en) Methods, compositions and articles for reducing or preventing the effects of inflammation.
ZA200108291B (en) Diaminothiazoles and their use for inhibiting protein kinases.
IL128801A (en) Pharmaceutical composition comprising a substance inhibiting no synthase
WO1996003515A3 (en) Surface expression of enzyme in gene directed prodrug therapy
AU4867697A (en) Oxadiazoles, processes for preparing them and their use as pharmaceutical compositions
NZ513629A (en) C-21 modified epothilones
EP1178786A4 (de) Protein stabilisierte pharmacologisch aktive wirkstoffe, verfahren zu deren herstellung und methoden zu deren anwendungen
AU6373094A (en) Enzyme-containing pharmaceutical or cosmetic composition, process for preparing the same and its use
IL193615A0 (en) New azaindoles for inhibiting protein kinases and pharmaceutical composition comprising the same
EP0993831A3 (de) Komponente und Zusammensetzungen zur Verabreichung von Wirkstoffen
WO2000054813A3 (en) Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
IL146119A0 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
AU1926001A (en) Novel human protein kinases and protein kinase-like enzymes
WO2001034641A8 (en) Antimicrobial activity of the first cationic cluster of human lactoferrin
WO2003048205A3 (fr) Proteines a activite inhibitrice de l'il-6
PL349393A1 (en) Sulphonyloxazolamines as therapeutic active ingredients
AU1650401A (en) Oxadiazole derivatives and drugs containing these derivatives as the active ingredient
MXPA02003660A (es) Composicion herbicida y adyuvante.
IL148345A0 (en) Methods of and compositions for inhibiting the proliferation of mammalian cells
EP0643038A3 (de) Polyfunktionelle kationische Tenside, deren Zusammensetzungen, Verfahren zu deren Herstellung und Verwendungen.
AU1650501A (en) 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
WO1997026918A3 (en) Ligand directed enzyme prodrug therapy
IL143299A0 (en) Pharmaceutical composition comprising 5-[[4- [3-methyl-4-oxo-3, 4-dihydro-2-quinazolinyl] methoxy] phenyl-methyl] thiadiazolidine-2, 4-dione and the process for its preparation
AU9462498A (en) Hysteromyoma remedy containing dienogest as the active ingredient